Peering Into Intellia Therapeutics's Recent Short Interest

Benzinga28minutes ago

Will Intellia Therapeutics (NASDAQ:NTLA) Spend Its Cash Wisely?

Simply Wall StDec 16 18:42

Why Intellia Therapeutics (NTLA) Is the Worst ARK Stock to Buy According to Short Sellers

Yahoo FinanceDec 12 00:57

Lilly Tops Morgan Stanley's Biopharma Pick List for 2025

Seeking AlphaDec 7 05:21

Express News | Intellia Therapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(C)(4)

BreakingsDec 4 05:01

Intellia Therapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

GlobeNewswireDec 4 05:01